CD8A and neoplasm: Immunohistochemical staining revealed that the number of tumor-infiltrating CD3+ T cells and CD8+ T cells in the group of mice treated with Ad-P19/DC or Ad-P23/DC was significantly greater than that in the group of mice treated with Ad-GFP/DC, Ad-WT/DC, or DC alone (Figure 4c).